Cost Of Revenue - Futura Medical PLC (LSE:FUM) - Alpha Spread

Futura Medical PLC
LSE:FUM

Watchlist Manager
Futura Medical PLC Logo
Futura Medical PLC
LSE:FUM
Watchlist
Price: 32.55 GBX -3.56% Market Closed
Market Cap: 98.3m GBX
Have any thoughts about
Futura Medical PLC?
Write Note

Futura Medical PLC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Futura Medical PLC
Cost of Revenue Peer Comparison

Comparables:
G
GSK
A
AZN
INDV
HIK
DPH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Futura Medical PLC
LSE:FUM
Cost of Revenue
-ÂŁ2.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
GlaxoSmithKline PLC
NYSE:GSK
Cost of Revenue
-ÂŁ8.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
-1%
A
AstraZeneca PLC
NASDAQ:AZN
Cost of Revenue
-$8.7B
CAGR 3-Years
-8%
CAGR 5-Years
-14%
CAGR 10-Years
-5%
Indivior PLC
LSE:INDV
Cost of Revenue
-$195m
CAGR 3-Years
-18%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Hikma Pharmaceuticals PLC
LSE:HIK
Cost of Revenue
-$1.6B
CAGR 3-Years
-10%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
Dechra Pharmaceuticals PLC
LSE:DPH
Cost of Revenue
-ÂŁ331.9m
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
-14%

See Also

What is Futura Medical PLC's Cost of Revenue?
Cost of Revenue
-2.7m GBP

Based on the financial report for Jun 30, 2024, Futura Medical PLC's Cost of Revenue amounts to -2.7m GBP.

What is Futura Medical PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-241%

Over the last year, the Cost of Revenue growth was -241%.

Back to Top